Two manufacturers of the widely used abortion pill mifepristone have urgently appealed to the Supreme Court , seeking to block an appellate court ruling that, just a day prior, halted mail-order access to the medication . This development marks the most significant shift in US abortion policy since the overturning of Roe v. Wade. Danco Laboratories, a maker of mifepristone, requested an emergency pause on the 5th U.S. Circuit Court of Appeals decision, arguing the ruling "injects immediate confusion and upheaval into highly time-sensitive medical decisions." GenBioPro, which produces a generic version of the drug, submitted a similar request to the high court. The New Orleans-based appeals court’s unanimous decision on Friday represented a substantial victory for abortion opponents. The ruling mandates that mifepristone be distributed solely in person and at clinics, effectively overriding regulations established by the federal Food and Drug Administration (FDA).…